Teva Pharm patent expiration
1. Airduo Digihaler patent expiration
AIRDUO DIGIHALER's oppositions filed in EPO
AIRDUO DIGIHALER IPR and PTAB Proceedings
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6718972 | TEVA PHARM | Dose metering system for medicament inhaler |
Jun, 2021
(3 years ago) | |
| US8006690 | TEVA PHARM | Reservoir pressure system for medicament inhaler |
Jun, 2021
(3 years ago) | |
| US6748947 | TEVA PHARM | De-agglomerator for breath-actuated dry powder inhaler |
Jun, 2021
(3 years ago) | |
| US6871646 | TEVA PHARM | De-agglomerator for breath-actuated dry powder inhaler |
Jun, 2021
(3 years ago) | |
| US6701917 | TEVA PHARM | Dose counter for medicament inhaler |
Jun, 2021
(3 years ago) | |
| US7540282 | TEVA PHARM | Reservoir pressure system for medicament inhaler |
May, 2023
(1 year, 4 months ago) | |
|
US7540282 (Pediatric) | TEVA PHARM | Reservoir pressure system for medicament inhaler |
Nov, 2023
(10 months ago) | |
| US9616024 | TEVA PHARM | Process for preparing a medicament |
Sep, 2024
(10 days ago) | |
| US9987229 | TEVA PHARM | Process for preparing a medicament |
Sep, 2024
(10 days ago) | |
|
US9987229 (Pediatric) | TEVA PHARM | Process for preparing a medicament |
Mar, 2025
(5 months from now) | |
|
US9616024 (Pediatric) | TEVA PHARM | Process for preparing a medicament |
Mar, 2025
(5 months from now) | |
| US9463288 | TEVA PHARM | Dry powder inhalation apparatus |
May, 2025
(8 months from now) | |
| US10765820 | TEVA PHARM | Dry powder inhalation apparatus |
May, 2025
(8 months from now) | |
|
US10765820 (Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Nov, 2025
(1 year, 2 months from now) | |
|
US9463288 (Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Nov, 2025
(1 year, 2 months from now) | |
| US8651103 | TEVA PHARM | Dry powder inhalation apparatus |
Mar, 2028
(3 years from now) | |
|
US8651103 (Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Sep, 2028
(4 years from now) | |
| US10195375 | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Feb, 2031
(6 years from now) | |
| US9731087 | TEVA PHARM | Dose counter for inhaler having a bore and shaft arrangement |
May, 2031
(6 years from now) | |
| US10022510 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(6 years from now) | |
| US10124131 | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(6 years from now) | |
| US9216260 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jun, 2031
(6 years from now) | |
|
US10195375 (Pediatric) | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Aug, 2031
(6 years from now) | |
|
US9731087 (Pediatric) | TEVA PHARM | Dose counter for inhaler having a bore and shaft arrangement |
Nov, 2031
(7 years from now) | |
|
US10022510 (Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Nov, 2031
(7 years from now) | |
|
US10124131 (Pediatric) | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Nov, 2031
(7 years from now) | |
|
US9216260 (Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Dec, 2031
(7 years from now) | |
| US10561808 | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jan, 2032
(7 years from now) | |
| US8978966 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jan, 2032
(7 years from now) | |
| US8714149 | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Feb, 2032
(7 years from now) | |
|
US10561808 (Pediatric) | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jul, 2032
(7 years from now) | |
|
US8978966 (Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jul, 2032
(7 years from now) | |
|
US8714149 (Pediatric) | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Aug, 2032
(7 years from now) | |
| US9066957 | TEVA PHARM | Dry powder inhaler |
Oct, 2034
(10 years from now) | |
| US9415008 | TEVA PHARM | Dry powder inhaler |
Oct, 2034
(10 years from now) | |
|
US9415008 (Pediatric) | TEVA PHARM | Dry powder inhaler |
Apr, 2035
(10 years from now) | |
|
US9066957 (Pediatric) | TEVA PHARM | Dry powder inhaler |
Apr, 2035
(10 years from now) | |
| US9782550 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2035
(10 years from now) | |
| US9782551 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2035
(10 years from now) | |
| US10918816 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Dec, 2035
(11 years from now) | |
|
US9782551 (Pediatric) | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Feb, 2036
(11 years from now) | |
|
US9782550 (Pediatric) | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Feb, 2036
(11 years from now) | |
|
US10918816 (Pediatric) | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Jun, 2036
(11 years from now) | |
| US10569034 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2036
(11 years from now) | |
|
US10569034 (Pediatric) | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Feb, 2037
(12 years from now) | |
| US11351317 | TEVA PHARM | Drug delivery device with electronics |
Feb, 2038
(13 years from now) | |
|
US11351317 (Pediatric) | TEVA PHARM | Drug delivery device with electronics |
Aug, 2038
(13 years from now) | |
| US11357935 | TEVA PHARM | Drug delivery device with electronics |
Sep, 2038
(14 years from now) | |
| US11000653 | TEVA PHARM | Inhaler |
Dec, 2038
(14 years from now) | |
|
US11000653 (Pediatric) | TEVA PHARM | Inhaler |
Jun, 2039
(14 years from now) | |
| US11969544 | TEVA PHARM | Inhalers and airflow adaptors therefor |
Aug, 2039
(14 years from now) | |
| US11344685 | TEVA PHARM | Drug delivery device with electronics |
Sep, 2039
(15 years from now) | |
|
US11344685 (Pediatric) | TEVA PHARM | Drug delivery device with electronics |
Mar, 2040
(15 years from now) | |
| US11439777 | TEVA PHARM | Drug delivery device with electronics |
May, 2040
(15 years from now) | |
| US11464923 | TEVA PHARM | Inhaler system |
Jun, 2040
(15 years from now) | |
| US11173259 | TEVA PHARM | Drug delivery device with electronics and power management |
Jul, 2040
(15 years from now) | |
|
US11173259 (Pediatric) | TEVA PHARM | Drug delivery device with electronics and power management |
Jan, 2041
(16 years from now) | |
| US11266796 | TEVA PHARM | Inhalation device with integrated electronics |
Feb, 2041
(16 years from now) | |
|
US11266796 (Pediatric) | TEVA PHARM | Inhalation device with integrated electronics |
Aug, 2041
(16 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Jan 27, 2020 |
| M(M-61) | Jul 09, 2024 |
| Pediatric Exclusivity(PED) | Jan 09, 2025 |
Drugs and Companies using FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE ingredient
Market Authorisation Date: 12 July, 2019
Treatment: Treatment of asthma
Dosage: POWDER
More Information on Dosage
AIRDUO DIGIHALER family patents
2. Airduo Respiclick patent expiration
AIRDUO RESPICLICK's oppositions filed in EPO
AIRDUO RESPICLICK IPR and PTAB Proceedings
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6446627 | TEVA PHARM | Inhaler dose counter |
Dec, 2017
(6 years ago) | |
| US6748947 | TEVA PHARM | De-agglomerator for breath-actuated dry powder inhaler |
Jun, 2021
(3 years ago) | |
| US8006690 | TEVA PHARM | Reservoir pressure system for medicament inhaler |
Jun, 2021
(3 years ago) | |
| US6871646 | TEVA PHARM | De-agglomerator for breath-actuated dry powder inhaler |
Jun, 2021
(3 years ago) | |
| US6718972 | TEVA PHARM | Dose metering system for medicament inhaler |
Jun, 2021
(3 years ago) | |
| US6701917 | TEVA PHARM | Dose counter for medicament inhaler |
Jun, 2021
(3 years ago) | |
| US7540282 | TEVA PHARM | Reservoir pressure system for medicament inhaler |
May, 2023
(1 year, 4 months ago) | |
|
US7540282 (Pediatric) | TEVA PHARM | Reservoir pressure system for medicament inhaler |
Nov, 2023
(10 months ago) | |
| US9616024 | TEVA PHARM | Process for preparing a medicament |
Sep, 2024
(10 days ago) | |
| US9987229 | TEVA PHARM | Process for preparing a medicament |
Sep, 2024
(10 days ago) | |
|
US9987229 (Pediatric) | TEVA PHARM | Process for preparing a medicament |
Mar, 2025
(5 months from now) | |
|
US9616024 (Pediatric) | TEVA PHARM | Process for preparing a medicament |
Mar, 2025
(5 months from now) | |
| US9463288 | TEVA PHARM | Dry powder inhalation apparatus |
May, 2025
(8 months from now) | |
| US10765820 | TEVA PHARM | Dry powder inhalation apparatus |
May, 2025
(8 months from now) | |
|
US10765820 (Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Nov, 2025
(1 year, 2 months from now) | |
|
US9463288 (Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Nov, 2025
(1 year, 2 months from now) | |
| US8651103 | TEVA PHARM | Dry powder inhalation apparatus |
Mar, 2028
(3 years from now) | |
|
US8651103 (Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Sep, 2028
(4 years from now) | |
| US10195375 | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Feb, 2031
(6 years from now) | |
| US10022510 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(6 years from now) | |
| US9731087 | TEVA PHARM | Dose counter for inhaler having a bore and shaft arrangement |
May, 2031
(6 years from now) | |
| US10124131 | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(6 years from now) | |
| US9216260 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jun, 2031
(6 years from now) | |
|
US10195375 (Pediatric) | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Aug, 2031
(6 years from now) | |
|
US10022510 (Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Nov, 2031
(7 years from now) | |
|
US9731087 (Pediatric) | TEVA PHARM | Dose counter for inhaler having a bore and shaft arrangement |
Nov, 2031
(7 years from now) | |
|
US10124131 (Pediatric) | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Nov, 2031
(7 years from now) | |
|
US9216260 (Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Dec, 2031
(7 years from now) | |
| US10561808 | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jan, 2032
(7 years from now) | |
| US8978966 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jan, 2032
(7 years from now) | |
| US8714149 | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Feb, 2032
(7 years from now) | |
|
US10561808 (Pediatric) | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jul, 2032
(7 years from now) | |
|
US8978966 (Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jul, 2032
(7 years from now) | |
|
US8714149 (Pediatric) | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Aug, 2032
(7 years from now) | |
| US9066957 | TEVA PHARM | Dry powder inhaler |
Oct, 2034
(10 years from now) | |
| US9415008 | TEVA PHARM | Dry powder inhaler |
Oct, 2034
(10 years from now) | |
|
US9415008 (Pediatric) | TEVA PHARM | Dry powder inhaler |
Apr, 2035
(10 years from now) | |
|
US9066957 (Pediatric) | TEVA PHARM | Dry powder inhaler |
Apr, 2035
(10 years from now) | |
| US11969544 | TEVA PHARM | Inhalers and airflow adaptors therefor |
Aug, 2039
(14 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Jan 27, 2020 |
| M(M-61) | Jul 09, 2024 |
| Pediatric Exclusivity(PED) | Jan 09, 2025 |
Drugs and Companies using FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE ingredient
Market Authorisation Date: 12 July, 2019
Treatment: Treatment of asthma
Dosage: POWDER
More Information on Dosage
AIRDUO RESPICLICK family patents
3. Armonair Digihaler patent
expiration
ARMONAIR DIGIHALER's oppositions filed in EPO
ARMONAIR DIGIHALER IPR and PTAB Proceedings
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6701917 | TEVA PHARM | Dose counter for medicament inhaler |
Jun, 2021
(3 years ago) | |
| US8006690 | TEVA PHARM | Reservoir pressure system for medicament inhaler |
Jun, 2021
(3 years ago) | |
| US6718972 | TEVA PHARM | Dose metering system for medicament inhaler |
Jun, 2021
(3 years ago) | |
| US6748947 | TEVA PHARM | De-agglomerator for breath-actuated dry powder inhaler |
Jun, 2021
(3 years ago) | |
| US6871646 | TEVA PHARM | De-agglomerator for breath-actuated dry powder inhaler |
Jun, 2021
(3 years ago) | |
| US7540282 | TEVA PHARM | Reservoir pressure system for medicament inhaler |
May, 2023
(1 year, 4 months ago) | |
|
US7540282 (Pediatric) | TEVA PHARM | Reservoir pressure system for medicament inhaler |
Nov, 2023
(10 months ago) | |
| US9616024 | TEVA PHARM | Process for preparing a medicament |
Sep, 2024
(10 days ago) | |
|
US9616024 (Pediatric) | TEVA PHARM | Process for preparing a medicament |
Mar, 2025
(5 months from now) | |
| US9463288 | TEVA PHARM | Dry powder inhalation apparatus |
May, 2025
(8 months from now) | |
| US10765820 | TEVA PHARM | Dry powder inhalation apparatus |
May, 2025
(8 months from now) | |
|
US10765820 (Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Nov, 2025
(1 year, 2 months from now) | |
|
US9463288 (Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Nov, 2025
(1 year, 2 months from now) | |
| US8651103 | TEVA PHARM | Dry powder inhalation apparatus |
Mar, 2028
(3 years from now) | |
|
US8651103 (Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Sep, 2028
(4 years from now) | |
| US10195375 | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Feb, 2031
(6 years from now) | |
| US9731087 | TEVA PHARM | Dose counter for inhaler having a bore and shaft arrangement |
May, 2031
(6 years from now) | |
| US10124131 | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(6 years from now) | |
| US10022510 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(6 years from now) | |
| US9216260 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jun, 2031
(6 years from now) | |
|
US10195375 (Pediatric) | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Aug, 2031
(6 years from now) | |
|
US9731087 (Pediatric) | TEVA PHARM | Dose counter for inhaler having a bore and shaft arrangement |
Nov, 2031
(7 years from now) | |
|
US10022510 (Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Nov, 2031
(7 years from now) | |
|
US10124131 (Pediatric) | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Nov, 2031
(7 years from now) | |
|
US9216260 (Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Dec, 2031
(7 years from now) | |
| US10561808 | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jan, 2032
(7 years from now) | |
| US8978966 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jan, 2032
(7 years from now) | |
| US8714149 | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Feb, 2032
(7 years from now) | |
|
US10561808 (Pediatric) | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jul, 2032
(7 years from now) | |
|
US8978966 (Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jul, 2032
(7 years from now) | |
|
US8714149 (Pediatric) | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Aug, 2032
(7 years from now) | |
| US9782550 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2035
(10 years from now) | |
| US9782551 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2035
(10 years from now) | |
| US10918816 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Dec, 2035
(11 years from now) | |
|
US9782551 (Pediatric) | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Feb, 2036
(11 years from now) | |
|
US9782550 (Pediatric) | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Feb, 2036
(11 years from now) | |
|
US10918816 (Pediatric) | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Jun, 2036
(11 years from now) | |
| US10569034 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2036
(11 years from now) | |
|
US10569034 (Pediatric) | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Feb, 2037
(12 years from now) | |
| US11351317 | TEVA PHARM | Drug delivery device with electronics |
Feb, 2038
(13 years from now) | |
|
US11351317 (Pediatric) | TEVA PHARM | Drug delivery device with electronics |
Aug, 2038
(13 years from now) | |
| US11357935 | TEVA PHARM | Drug delivery device with electronics |
Sep, 2038
(14 years from now) | |
| US11000653 | TEVA PHARM | Inhaler |
Dec, 2038
(14 years from now) | |
|
US11357935 (Pediatric) | TEVA PHARM | Drug delivery device with electronics |
Mar, 2039
(14 years from now) | |
|
US11000653 (Pediatric) | TEVA PHARM | Inhaler |
Jun, 2039
(14 years from now) | |
| US11969544 | TEVA PHARM | Inhalers and airflow adaptors therefor |
Aug, 2039
(14 years from now) | |
| US11344685 | TEVA PHARM | Drug delivery device with electronics |
Sep, 2039
(15 years from now) | |
|
US11344685 (Pediatric) | TEVA PHARM | Drug delivery device with electronics |
Mar, 2040
(15 years from now) | |
| US11439777 | TEVA PHARM | Drug delivery device with electronics |
May, 2040
(15 years from now) | |
| US11464923 | TEVA PHARM | Inhaler system |
Jun, 2040
(15 years from now) | |
| US11173259 | TEVA PHARM | Drug delivery device with electronics and power management |
Jul, 2040
(15 years from now) | |
|
US11439777 (Pediatric) | TEVA PHARM | Drug delivery device with electronics |
Nov, 2040
(16 years from now) | |
|
US11464923 (Pediatric) | TEVA PHARM | Inhaler system |
Dec, 2040
(16 years from now) | |
|
US11173259 (Pediatric) | TEVA PHARM | Drug delivery device with electronics and power management |
Jan, 2041
(16 years from now) | |
| US11266796 | TEVA PHARM | Inhalation device with integrated electronics |
Feb, 2041
(16 years from now) | |
|
US11266796 (Pediatric) | TEVA PHARM | Inhalation device with integrated electronics |
Aug, 2041
(16 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Jan 27, 2020 |
| New Strength(NS) | Jul 09, 2024 |
| New Patient Population(NPP) | Jul 09, 2024 |
| Pediatric Exclusivity(PED) | Jan 09, 2025 |
Drugs and Companies using FLUTICASONE PROPIONATE ingredient
Market Authorisation Date: 08 April, 2022
Treatment: NA
Dosage: POWDER
More Information on Dosage
ARMONAIR DIGIHALER family patents
4. Armonair Respiclick patent expiration
ARMONAIR RESPICLICK's oppositions filed in EPO
ARMONAIR RESPICLICK IPR and PTAB Proceedings
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6446627 | TEVA PHARM | Inhaler dose counter |
Dec, 2017
(6 years ago) | |
| US6701917 | TEVA PHARM | Dose counter for medicament inhaler |
Jun, 2021
(3 years ago) | |
| US6718972 | TEVA PHARM | Dose metering system for medicament inhaler |
Jun, 2021
(3 years ago) | |
| US8006690 | TEVA PHARM | Reservoir pressure system for medicament inhaler |
Jun, 2021
(3 years ago) | |
| US6748947 | TEVA PHARM | De-agglomerator for breath-actuated dry powder inhaler |
Jun, 2021
(3 years ago) | |
| US6871646 | TEVA PHARM | De-agglomerator for breath-actuated dry powder inhaler |
Jun, 2021
(3 years ago) | |
| US7540282 | TEVA PHARM | Reservoir pressure system for medicament inhaler |
May, 2023
(1 year, 4 months ago) | |
|
US7540282 (Pediatric) | TEVA PHARM | Reservoir pressure system for medicament inhaler |
Nov, 2023
(10 months ago) | |
| US9616024 | TEVA PHARM | Process for preparing a medicament |
Sep, 2024
(10 days ago) | |
|
US9616024 (Pediatric) | TEVA PHARM | Process for preparing a medicament |
Mar, 2025
(5 months from now) | |
| US9463288 | TEVA PHARM | Dry powder inhalation apparatus |
May, 2025
(8 months from now) | |
| US10765820 | TEVA PHARM | Dry powder inhalation apparatus |
May, 2025
(8 months from now) | |
|
US9463288 (Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Nov, 2025
(1 year, 2 months from now) | |
|
US10765820 (Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Nov, 2025
(1 year, 2 months from now) | |
| US8651103 | TEVA PHARM | Dry powder inhalation apparatus |
Mar, 2028
(3 years from now) | |
|
US8651103 (Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Sep, 2028
(4 years from now) | |
| US10195375 | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Feb, 2031
(6 years from now) | |
| US10124131 | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(6 years from now) | |
| US10022510 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(6 years from now) | |
| US9731087 | TEVA PHARM | Dose counter for inhaler having a bore and shaft arrangement |
May, 2031
(6 years from now) | |
| US9216260 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jun, 2031
(6 years from now) | |
|
US10195375 (Pediatric) | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Aug, 2031
(6 years from now) | |
|
US10124131 (Pediatric) | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Nov, 2031
(7 years from now) | |
|
US9731087 (Pediatric) | TEVA PHARM | Dose counter for inhaler having a bore and shaft arrangement |
Nov, 2031
(7 years from now) | |
|
US10022510 (Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Nov, 2031
(7 years from now) | |
|
US9216260 (Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Dec, 2031
(7 years from now) | |
| US10561808 | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jan, 2032
(7 years from now) | |
| US8978966 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jan, 2032
(7 years from now) | |
| US8714149 | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Feb, 2032
(7 years from now) | |
|
US10561808 (Pediatric) | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jul, 2032
(7 years from now) | |
|
US8978966 (Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jul, 2032
(7 years from now) | |
|
US8714149 (Pediatric) | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Aug, 2032
(7 years from now) | |
| US10918816 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Dec, 2035
(11 years from now) | |
| US11969544 | TEVA PHARM | Inhalers and airflow adaptors therefor |
Aug, 2039
(14 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Jan 27, 2020 |
| New Strength(NS) | Jul 09, 2024 |
| New Patient Population(NPP) | Jul 09, 2024 |
| Pediatric Exclusivity(PED) | Jan 09, 2025 |
Drugs and Companies using FLUTICASONE PROPIONATE ingredient
Market Authorisation Date: 08 April, 2022
Treatment: NA
Dosage: POWDER
More Information on Dosage
ARMONAIR RESPICLICK family patents